114 related articles for article (PubMed ID: 11332612)
1. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma.
Asp J; Inerot S; Block JA; Lindahl A
J Orthop Res; 2001 Jan; 19(1):149-54. PubMed ID: 11332612
[TBL] [Abstract][Full Text] [Related]
2. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis.
Bartkova J; Lukas J; Guldberg P; Alsner J; Kirkin AF; Zeuthen J; Bartek J
Cancer Res; 1996 Dec; 56(23):5475-83. PubMed ID: 8968104
[TBL] [Abstract][Full Text] [Related]
3. [The expression of p16, CDK4 and pRb in hepatocellular carcinomas].
Luo D; Liu Q; Su J
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):94-5. PubMed ID: 10488417
[TBL] [Abstract][Full Text] [Related]
4. Alteration of pRb/p16/cdk4 regulation in human osteosarcoma.
Benassi MS; Molendini L; Gamberi G; Ragazzini P; Sollazzo MR; Merli M; Asp J; Magagnoli G; Balladelli A; Bertoni F; Picci P
Int J Cancer; 1999 Oct; 84(5):489-93. PubMed ID: 10502725
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression.
Geradts J; Kratzke RA; Niehans GA; Lincoln CE
Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382
[TBL] [Abstract][Full Text] [Related]
6. [The effects of exogenous p16 expression on CDK4, Cyclin D1 and pRb in nasopharyngeal carcinoma cell lines].
Zhao XR; Deng L; Weng XX
Hunan Yi Ke Da Xue Xue Bao; 2000 Oct; 25(5):428-30. PubMed ID: 12212108
[TBL] [Abstract][Full Text] [Related]
7. CDKN2/p16 or RB alterations occur in the majority of glioblastomas and are inversely correlated.
Ueki K; Ono Y; Henson JW; Efird JT; von Deimling A; Louis DN
Cancer Res; 1996 Jan; 56(1):150-3. PubMed ID: 8548755
[TBL] [Abstract][Full Text] [Related]
8. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors.
Kovar H; Jug G; Aryee DN; Zoubek A; Ambros P; Gruber B; Windhager R; Gadner H
Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981
[TBL] [Abstract][Full Text] [Related]
9. Alterations of the cyclin D1/p16-pRB pathway in mantle cell lymphoma.
Dreyling MH; Bullinger L; Ott G; Stilgenbauer S; Müller-Hermelink HK; Bentz M; Hiddemann W; Döhner H
Cancer Res; 1997 Oct; 57(20):4608-14. PubMed ID: 9377576
[TBL] [Abstract][Full Text] [Related]
10. CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations.
Nielsen GP; Burns KL; Rosenberg AE; Louis DN
Am J Pathol; 1998 Jul; 153(1):159-63. PubMed ID: 9665476
[TBL] [Abstract][Full Text] [Related]
11. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma.
Yao J; Pollock RE; Lang A; Tan M; Pisters PW; Goodrich D; El-Naggar A; Yu D
Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903
[TBL] [Abstract][Full Text] [Related]
12. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features.
Semczuk A; Miturski R; Skomra D; Jakowicki JA
Arch Gynecol Obstet; 2004 Jan; 269(2):104-10. PubMed ID: 14648178
[TBL] [Abstract][Full Text] [Related]
13. Variable expression of p16 protein in patients with acute myeloid leukemia without gross rearrangements at the DNA level.
Jamal R; Thomas NS; Gale RE; Linch DC
Leukemia; 1996 Apr; 10(4):629-36. PubMed ID: 8618439
[TBL] [Abstract][Full Text] [Related]
14. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the pRb/p16/cdk4/cyclin D1 pathway in the tumorigenesis of sporadic malignant melanomas.
Maelandsmo GM; Flørenes VA; Hovig E; Oyjord T; Engebraaten O; Holm R; Børresen AL; Fodstad O
Br J Cancer; 1996 Apr; 73(8):909-16. PubMed ID: 8611425
[TBL] [Abstract][Full Text] [Related]
16. p16/pRb pathway alterations are required for bypassing senescence in human prostate epithelial cells.
Jarrard DF; Sarkar S; Shi Y; Yeager TR; Magrane G; Kinoshita H; Nassif N; Meisner L; Newton MA; Waldman FM; Reznikoff CA
Cancer Res; 1999 Jun; 59(12):2957-64. PubMed ID: 10383161
[TBL] [Abstract][Full Text] [Related]
17. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas.
Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M
Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the D-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb.
Li Y; Nichols MA; Shay JW; Xiong Y
Cancer Res; 1994 Dec; 54(23):6078-82. PubMed ID: 7954450
[TBL] [Abstract][Full Text] [Related]
19. HPV infection and the alterations of the pRB pathway in oral carcinogenesis.
Lim KP; Hamid S; Lau SH; Teo SH; Cheong SC
Oncol Rep; 2007 Jun; 17(6):1321-6. PubMed ID: 17487385
[TBL] [Abstract][Full Text] [Related]
20. Effects of adenovirus-mediated p16INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells.
Craig C; Kim M; Ohri E; Wersto R; Katayose D; Li Z; Choi YH; Mudahar B; Srivastava S; Seth P; Cowan K
Oncogene; 1998 Jan; 16(2):265-72. PubMed ID: 9464545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
